In a regulatory filing, Dentsply Sirona (XRAY) disclosed that its director Gregory Lucier bought 15.1K shares of common stock on March 3rd in a total transaction size of $250K.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Hold Rating Maintained for DENTSPLY SIRONA Amid Market Challenges and Strategic Uncertainty
- DENTSPLY SIRONA’s Mixed Earnings Call Insights
- Dentsply Sirona price target lowered to $20 from $24 at Barrington
- Dentsply Sirona price target lowered to $20 from $22 at Baird
- Dentsply Sirona price target lowered to $19 from $20 at Wells Fargo